Back to Search
Start Over
Oncogenes as Novel Targets for Cancer Therapy (Part III): Transcription Factors.
- Source :
- American Journal of PharmacoGenomics; 2005, Vol. 5 Issue 5, p327-338, 12p
- Publication Year :
- 2005
-
Abstract
- This is the third paper in a four-part serial review on potential therapeutic targeting of oncogenes. The previous parts described the involvement of oncogenes in different aspects of cancer growth and development, and considered the new technologies responsible for the advancement of oncogene identification, target validation, and drug design. Because of such advances, new specific and more efficient therapeutic agents can be developed for cancer. This part of the review continues the exploration of various oncogenes that we have grouped within seven categories: growth factors, tyrosine kinases, intermediate signaling molecules, transcription factors, cell cycle regulators, DNA damage repair genes, and genes involved in apoptosis. Part one discussed growth factors and tyrosine kinases and part two discussed intermediate signaling molecules. This portion of the review covers transcription factors and the various strategies being used to inhibit their expression or decrease their activities. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 11752203
- Volume :
- 5
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- American Journal of PharmacoGenomics
- Publication Type :
- Academic Journal
- Accession number :
- 18442326
- Full Text :
- https://doi.org/10.2165/00129785-200505050-00005